NLRC5
Basic information
Region (hg38): 16:56989485-57083531
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRC5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 89 | 11 | 102 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 89 | 16 | 4 |
Variants in NLRC5
This is a list of pathogenic ClinVar variants found in the NLRC5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-57020544-T-C | not provided (-) | |||
16-57020726-G-T | not specified | Uncertain significance (Oct 14, 2021) | ||
16-57020780-A-C | not specified | Uncertain significance (Aug 02, 2022) | ||
16-57020800-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
16-57020828-C-T | not specified | Likely benign (Mar 31, 2022) | ||
16-57020838-T-G | not specified | Uncertain significance (Apr 13, 2022) | ||
16-57020848-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
16-57020859-C-G | not specified | Uncertain significance (Apr 24, 2024) | ||
16-57020867-A-G | not specified | Uncertain significance (Jun 09, 2022) | ||
16-57020990-C-G | not specified | Uncertain significance (Jun 28, 2022) | ||
16-57022227-A-C | not provided (-) | |||
16-57023663-C-T | not provided (-) | |||
16-57023697-G-A | not provided (-) | |||
16-57023899-C-G | not provided (-) | |||
16-57024091-C-T | not provided (-) | |||
16-57024129-C-T | not provided (-) | |||
16-57025406-G-A | not specified | Uncertain significance (May 11, 2022) | ||
16-57025419-A-G | not specified | Uncertain significance (Aug 08, 2023) | ||
16-57025425-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
16-57025491-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
16-57025493-G-A | not specified | Uncertain significance (May 26, 2022) | ||
16-57025538-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
16-57025539-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
16-57025557-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
16-57025587-C-G | not specified | Uncertain significance (Mar 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NLRC5 | protein_coding | protein_coding | ENST00000262510 | 47 | 94047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.42e-8 | 1.00 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.01 | 837 | 1.02e+3 | 0.823 | 0.0000582 | 12102 |
Missense in Polyphen | 101 | 185.24 | 0.54524 | 2596 | ||
Synonymous | 0.748 | 424 | 444 | 0.955 | 0.0000268 | 3816 |
Loss of Function | 5.90 | 30 | 90.6 | 0.331 | 0.00000430 | 1062 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000548 | 0.000544 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000436 | 0.000416 |
European (Non-Finnish) | 0.000360 | 0.000352 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000164 | 0.000163 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Probable regulator of the NF-kappa-B and type I interferon signaling pathways. May also regulate the type II interferon signaling pathway. Plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. {ECO:0000269|PubMed:20061403, ECO:0000269|PubMed:20434986}.;
- Pathway
- DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling
(Consensus)
Recessive Scores
- pRec
- 0.0897
Intolerance Scores
- loftool
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.3
Haploinsufficiency Scores
- pHI
- 0.0793
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.474
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.277
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nlrc5
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- response to bacterium;negative regulation of NF-kappaB transcription factor activity;negative regulation of type I interferon production;intracellular signal transduction;regulation of kinase activity;innate immune response;positive regulation of MHC class I biosynthetic process;positive regulation of transcription by RNA polymerase II;defense response to virus;positive regulation of interferon-gamma-mediated signaling pathway;negative regulation of type I interferon-mediated signaling pathway;positive regulation of type I interferon-mediated signaling pathway
- Cellular component
- nucleus;cytoplasm;centrosome;cytosol
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;protein binding;ATP binding